NIAID Banner Logo Image

Mycobacterium Citations List: June, 2016

Literature Citations

1. New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-specific T Cells. Abate, G., P.G. Ruminiski, M. Kumar, K. Singh, F. Hamzabegovic, D.F. Hoft, C.S. Eickhoff, A. Selimovic, M. Campbell, and K. Chibale. Antimicrobial Agents and Chemotherapy, 2016. 60(3): p. 1216-1225. PMID[26643325]. PMCID[PMC4775996].
[PubMed]
. TB_06_2015.


2. Synthesis, Structure, Antimycobacterial and Anticancer Evaluation of New Pyrrolo-phenanthroline Derivatives. Al Matarneh, C.M., Mangalagiu, II, S. Shova, and R. Danac. Journal of Enzyme Inhibition and Medicinal Chemistry, 2016. 31(3): p. 470-480. PMID[25945747].
[PubMed]
. TB_06_2015.


3. Synthesis and Antimicrobial Activity of 4-Chloro-3-nitrophenylthiourea Derivatives Targeting Bacterial Type II Topoisomerases. Bielenica, A., K. Stepien, A. Napiorkowska, E. Augustynowicz-Kopec, S. Krukowski, M. Wlodarczyk, and M. Struga. Chemical Biology and Drug Design, 2016. 87(6): p. 905-917. PMID[26804238].
[PubMed]
. TB_06_2015.


4. In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest. Brown-Elliott, B.A., J. Killingley, S. Vasireddy, L. Bridge, and R.J. Wallace, Jr. Journal of Clinical Microbiology, 2016. 54(6): p. 1586-1592. PMID[27053677]. PMCID[PMC4879266].
[PubMed]
. TB_06_2015.


5. Synthesis and Biological Activity of the Liposidomycins and Caprazamycins, Members of a Novel Class of Diazepanone-containing Nucleosides. Cheng-Sanchez, I., C. Garcia-Ruiz, J.I. Trujillo, and F. Sarabia. Targets in Heterocyclic Systems: Chemistry and Properties, 2015. 19: p. 239-273. ISI[000375721900010].

[WOS]. TB_06_2015.


6. Indole-based Hydrazide-hydrazones and 4-Thiazolidinones: Synthesis and Evaluation as Antitubercular and Anticancer Agents. Cihan-Ustundag, G., D. Satana, G. Ozhan, and G. Capan. Journal of Enzyme Inhibition and Medicinal Chemistry, 2016. 31(3): p. 369-380. PMID[25910087].
[PubMed]
. TB_06_2015.


7. Anti-mycobacterial Activity of Polyketides from Penicillium sp. endophyte Isolated from Garcinia nobilis against Mycobacterium smegmatis. Jouda, J.B., I.K. Mawabo, A. Notedji, C.D. Mbazoa, J. Nkenfou, J. Wandji, and C.N. Nkenfou. International Journal of Mycobacteriology, 2016. 5(2): p. 192-196. PMID[27242231].
[PubMed]
. TB_06_2015.


8. 2-Aryl-8-aza-3-deazaadenosine Analogues of 5'-O- N-(salicyl)sulfamoyl Adenosine: Nucleoside Antibiotics That Block Siderophore Biosynthesis in Mycobacterium tuberculosis. Krajczyk, A., J. Zeidler, P. Januszczyk, S. Dawadi, H.I. Boshoff, C.E. Barry, T. Ostrowski, and C.C. Aldrich. Bioorganic & Medicinal Chemistry, 2016. 24(14): p. 3133-3143. PMID[27265685]. PMCID[PMC4914392].
[PubMed]
. TB_06_2015.


9. Design, Synthesis and Bioactivity Evaluation of Galf Mimics as Antitubercular Agents. Liu, C., L. Hou, A. Meng, G. Han, W. Zhang, and S. Jiang. Carbohydrate Research, 2016. 429: p. 135-142. PMID[26706033].
[PubMed]
. TB_06_2015.


10. Novel TetR Family Transcriptional Factor Regulates Expression of Multiple Transport-related Genes and Affects Rifampicin Resistance in Mycobacterium smegmatis. Liu, H., M. Yang, and Z.G. He. Scientific Reports, 2016. 6( 27489): 10pp. PMID[27271013]. PMCID[PMC4895335].
[PubMed]
. TB_06_2015.


11. Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as New Anti-mycobacterial Chemotypes: Design, Synthesis, Biological Evaluation and 3D-QSAR Studies. Pancholia, S., T.M. Dhameliya, P. Shah, P.S. Jadhavar, J.P. Sridevi, P. Yogeshwari, D. Sriram, and A.K. Chakraborti. European Journal of Medicinal Chemistry, 2016. 116: p. 187-199. PMID[27061982].
[PubMed]
. TB_06_2015.


12. Synthesis and Evaluation of Original Bioisosteres of Bacterial Type IIA Topoisomerases Inhibitors. Petrella, S., A. Aubry, G. Janvier, E.P. Coutant, A. Cartier, T.H. Dao, F.J. Bonhomme, L. Motreff, C. Pissis, C. Bizet, D. Clermont, E. Begaud, P. Retailleau, H. Munier-Lehmann, E. Capton, C. Mayer, and Y.L. Janin. Canadian Journal of Chemistry, 2016. 94(3): p. 240-250. ISI[000375955900008].
[WOS]
. TB_06_2015.


13. Screening of Antitubercular Compound Library Identifies Novel Shikimate Kinase Inhibitors of Mycobacterium tuberculosis. Rajput, V.S., R. Mehra, S. Kumar, A. Nargotra, P.P. Singh, and I.A. Khan. Applied Microbiology and Biotechnology, 2016. 100(12): p. 5415-5426. PMID[26887318].
[PubMed]
. TB_06_2015.


14. Small-molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents. Sandhaus, S., T. Annamalai, G. Welmaker, R.A. Houghten, C. Paz, P.K. Garcia, A. Andres, G. Narula, C. Rodrigues Felix, S. Geden, M. Netherton, R. Gupta, K.H. Rohde, M.A. Giulianotti, and Y.C. Tse-Dinh. Antimicrobial Agents and Chemotherapy, 2016. 60(7): p. 4028-4036. PMID[27114277]. PMCID[PMC4914652].
[PubMed]
. TB_06_2015.


15. Limonia acidissima L. Leaf Mediated Synthesis of Zinc Oxide Nanoparticles: A Potent Tool against Mycobacterium tuberculosis. Taranath, T.C. and B.N. Patil. International Journal of Mycobacteriology, 2016. 5(2): p. 197-204. PMID[27242232].
[PubMed]
. TB_06_2015.


16. Synthesis and Evaluation of New 2-Aminothiophenes against Mycobacterium tuberculosis. Thanna, S., S.E. Knudson, A. Grzegorzewicz, S. Kapil, C.M. Goins, D.R. Ronning, M. Jackson, R.A. Slayden, and S.J. Sucheck. Organic & Biomolecular Chemistry, 2016. 14(25): p. 6119-6133. PMID[27251120]. PMCID[PMC4918453].
[PubMed]
. TB_06_2015.


17. Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis. Willby, M.J., K.D. Green, C.S. Gajadeera, C. Hou, O.V. Tsodikov, J.E. Posey, and S. Garneau-Tsodikova. ACS Chemical Biology, 2016. 11(6): p. 1639-1646. PMID[27010218].
[PubMed]
. TB_06_2015.


18. Reduction of Minimum Inhibitory Concentrations in Drug-resistant Mycobacterium tuberculosis Isolates in the Presence of Efflux Pump Inhibitors. Yadav, R., S.K. Dhatwalia, A. Mewara, D. Behera, and S. Sethi. Journal of Global Antimicrobial Resistance, 2016. 5: p. 88-89. ISI[000376654400021].
[WOS]
. TB_06_2015.


19. Nontoxic Metal-cyclam Complexes, a New Class of Compounds with Potency against Drug-resistant Mycobacterium tuberculosis. Yu, M., G. Nagalingam, S. Ellis, E. Martinez, V. Sintchenko, M. Spain, P.J. Rutledge, M.H. Todd, and J.A. Triccas. Journal of Medicinal Chemistry, 2016. 59(12): p. 5917-5921. PMID[27214150].
[PubMed]
. TB_06_2015.


20. Antimycobacterial Activity of New N(1)-[1-[1-aryl-3-[ 4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone Derivatives. Zampieri, D., M.G. Mamolo, L. Vio, M. Romano, N. Skoko, M. Baralle, V. Pau, and A. De Logu. Bioorganic & Medicinal Chemistry Letters, 2016. 26(14): p. 3287-3290. PMID[27241693].
[PubMed]
. TB_06_2015.


21. Design, Synthesis and Anti-mycobacterial Evaluation of Some New N-Phenylpyrazine-2-carboxamides. Zitko, J., B. Servusova-Vanaskova, P. Paterova, L. Navratilova, F. Trejtnar, J. Kunes, and M. Dolezal. Chemical Papers, 2016. 70(5): p. 649-657. ISI[000376512000014].
[WOS]
. TB_06_2015.

Patent Citations

22. Novel Cystobactamides of Cystobacter as Antibiotics and Synthesis of Cystobactamide C Derivatives. Baumann, S., J. Herrmann, K. Mohr, H. Steinmetz, K. Gerth, R. Raju, R. Mueller, R. Hartmann, M. Hamed, W.A.M. Elgaher, M. Moreno, F. Gille, L.L. Wang, A. Kirschning, and S. Huettel. Patent. 2016. 2015-EP2382 2016082934: 81pp.

[Patent]. TB_06_2016.


23. Substituted 2-(2-Phenylhydrazinyl)pyrazine, Process for Its Preparation, Its Use and a Pharmaceutical Composition Containing the Same. Dolezal, M., J. Zitko, O. Jandourek, and B. Servusova-Vanaskova. Patent. 2016. 2015-CZ127 2016095877: 31pp.

[Patent]. TB_06_2016.


24. Composition Comprising Vancomycin and Orlistat. Fontaine, V. and P. Lefevre. Patent. 2016. 2015-EP80933 2016102541: 56pp.

[Patent]. TB_06_2016.


25. Preparation of Imidazole-Based Antimicrobial Agents. Oender, K., R. Datema, D. Mitchell, and I. Kondratov. Patent. 2016. 2015-EP78587 2016087618: 308pp.

[Patent]. TB_06_2016.


26. Preparation of 3,5-Dinitrophenyltetrazoles and Pharmaceutical Preparation Containing the Same for the Treatment of Tuberculosis. Roh, J., J. Nemecek, A. Hrabalek, V. Klimesova, G. Karabanovich, P. Pavek, and P. Sychra. Patent. 2016. 2015-CZ126 2016091228: 26pp.

[Patent]. TB_06_2016.


27. Substituted Derivative of Oxyphosphorus acids, Its Use and Pharmaceutical Preparation Containing It. Vinsova, J., M. Kratky, and G. Paraskevopoulos. Patent. 2016. 2015-CZ129 2016095878: 39pp.

[Patent]. TB_06_2016.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024